All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

324

Reset

324 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • FMC-376Phase 22 trials

    Frontier Medicines Corporation · Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor

  • IBB0979Phase 22 trials

    SUNHO(China)BioPharmaceutical CO., Ltd. · Small Cell Lung Cancer, Advanced Malignant Tumors

  • IDP-121Phase 22 trials

    IDP Discovery Pharma S.L. · Small Cell Lung Cancer ( SCLC ), Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

  • ImzokitugBMS-986340Phase 22 trials

    Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer

  • KB707Phase 22 trials

    Krystal Biotech, Inc. · Cancer, Melanoma Stage III, Melanoma Stage IV

  • KCBT-1083BEBT-109Phase 22 trials

    BeBetter Med Inc · Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation

  • KN046Recombinant Humanized PD-L1, CTLA-4 Bispecific Single Domain Antibody Fc Fusion ProteinPhase 22 trials

    InxMed (Shanghai) Co., Ltd. · Pancreatic Cancer, Advanced Non-small Cell Lung Cancer

  • LM103 TILsPhase 22 trials

    Suzhou BlueHorse Therapeutics Co., Ltd. · Advanced Melanoma, Non-Small Cell Lung Cancer

  • LS301-ITPhase 22 trials

    Integro Theranostics · Non Small Cell Lung Cancer (NSCLC), Breast Cancer, DCIS

  • M1774TuvusertibPhase 22 trials

    EMD Serono Research & Development Institute, Inc. · Non-Small Cell Lung Cancer, Ovarian Cancer

  • NelistotugGSK6097608Phase 22 trials

    GSK · Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck

  • NelmastobartPhase 22 trials

    STCube, Inc. · Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer, Non Small Cell Lung Cancer

  • ODM-212Phase 22 trials

    Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer

  • Suzhou BlueHorse Therapeutics Co., Ltd. · Non-Small Cell Lung Cancer, Advanced Malignant Solid Tumor

  • PF-07104091ovarian, SCLCPhase 22 trials

    Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer

  • quaratusugene ozeplasmidREQORSAPhase 22 trials

    Genprex, Inc. · Carcinoma, Non-Small Cell Lung, Small Cell Lung Cancer Extensive Stage

  • QuavonlimabMK-1308Phase 22 trials

    Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer

  • RAPA-201 Rapamycin Resistant T CellsRAPA-201 cellsPhase 22 trials

    Rapa Therapeutics LLC · Malignant Melanoma, Malignant Melanoma With Metastasis, Malignant Melanoma Stage IIIc

  • RC108Phase 22 trials

    RemeGen Co., Ltd. · Non-Small Cell Lung Cancer, Digestive Cancer

  • RDEABSK141-Recommended Expansion, S095018 RecommendedPhase 22 trials

    Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult, Non-small Cell Lung Cancer (NSCLC)

  • S095029Phase 22 trials

    Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer

  • silevertinibBDTX-1535Phase 22 trials

    Black Diamond Therapeutics, Inc. · Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM

  • SKB500Phase 22 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Esophageal Squamous Cell Carcinoma, Small Cell Lung Cancer

  • SPGL008Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · NMIBC, Non Small Cell Lung Cancer

  • Sutetinib MaleatePhase 22 trials

    Teligene US · Non-small Cell Lung Cancer

  • TCC1727Phase 22 trials

    Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)

  • TNO155Phase 22 trials

    Novartis · Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation, KRAS G12C Mutant Solid Tumors

  • ABT-101DBPR112Phase 21 trial

    Anbogen Therapeutics, Inc. · Advanced Solid Tumor, Non Small Cell Lung Cancer, HER2 Mutations

  • adebeliizumabPhase 21 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer

  • AFNT-211Phase 21 trial

    Affini-T Therapeutics, Inc. · Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, Colorectal Cancer

  • ALK202Phase 21 trial

    Shanghai Allink Biotherapeutics Co., Ltd. · NSCLC (Advanced Non-small Cell Lung Cancer)

  • Alomnertinib MesilatePhase 21 trial

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer

  • and CarboplatinPhase 21 trial

    CrystalGenomics, Inc. · Non Squamous Non Small Cell Lung Cancer

  • ANS014004Phase 21 trial

    Beijing Pearl Biotechnology Limited Liability Company · Non-Small Cell Lung Cancer, EGFR Mutation, Metastatic Lung Cancer

  • ANS02Phase 21 trial

    Avistone Biotechnology Co., Ltd. · Non-Small Cell Lung Cancer

  • AP203Phase 21 trial

    AP Biosciences Inc. · Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)

  • ATX-295Phase 21 trial

    Accent Therapeutics · Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer

  • AU-007Phase 21 trial

    Aulos Bioscience, Inc. · Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma

  • AZD2811Phase 21 trial

    AstraZeneca · Small-Cell Lung Cancer

  • AZD6750Phase 21 trial

    AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)

  • AZD7789Phase 21 trial

    AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer

  • AZD8205Phase 21 trial

    AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer

  • BBT-207Phase 21 trial

    Bridge Biotherapeutics, Inc. · EGFR Mutant Advanced Non-Small Cell Lung Cancer

  • BH-30643Phase 21 trial

    BlossomHill Therapeutics · NSCLC (Advanced Non-small Cell Lung Cancer)

  • BI-1910Phase 21 trial

    BioInvent International AB · Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma

  • BLU-924SAR449336Phase 21 trial

    Blueprint Medicines Corporation · Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms

  • BMS-986012Phase 21 trial

    Bristol Myers Squibb · Extensive-stage Small Cell Lung Cancer

  • BMS-986523Phase 21 trial

    Bristol Myers Squibb · Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

  • BMS-986525Phase 21 trial

    Bristol Myers Squibb · Relapsed/Refractory Small Cell Lung Cancer

  • BNT116Phase 21 trial

    Regeneron · Advanced Non-Small Cell Lung Cancer

NewerPage 5 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.